Hemostasis Assays Flashcards
how is blood kept from clotting during a coagulation screening test?
- remove calcium using citrate
general activating agents for tests of coagulation
- calcium
- phospholipid
routine coagulation tests
- prothrombin time (PT)
- activated partial thromboplastin time (aPTT)
- thrombin time (TT) or thrombin clotting time (TCT)
TCT tests for
- conversion of fibrinogen to fibrin
- using thrombin
activating agents for thrombin time
- we do not use activating agents
how to do a TT test
- citrated plasma
- add thrombin
- record the time until clot forms
what causes a prolonged TT
- low fibrinogen
- abnormal fibrinogen
- inhibitor of added thrombin
another name for low fibrinogen
- hypofibrinogenemia
another name for abnormal fibrinogen
- dysfibrinogenemia
ways to get abnormal fibrinogen
- inherited
- acquired
acquired abnormal fibrinogen from
- severe liver disease
ways to get inhibitor of added thrombin
- direct inhibitor
- indirect inhibitor
direct inhibitor example
- argatroban
- dabigatran
indirect inhibitor example
- heparin
how to do the prothrombin time
- citrated plasma
- add thromboplastin and calcium
- record the time until clot forms
thromboplastin provides which compounds
- tissue factor
- phospholipid
prothrombin time measures which part of the coagulation cascade
- extrinsic pathway
if TF/VIIa can also activate factor 9, how come the PT is not sensitive to factor8/9 deficiency?
- the TF in vast excess drives the pathway toward X activation only
what causes a prolonged PT
- anything that prolongs the TT
- anything that lowers levels or inhibits common pathway factors
- low levels of Factor 7
sensitivity of PT compared to TT
- PT much less sensitive than TT
what things is the PT much less sensitive to
- heparin
- abnormal fibrinogen
- FDPs
the common pathway factors
- 10
- 5
- 2 (prothrombin)
- fibrinogen
how do we get low levels of factor 7?
- congenital
- acquired